| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $636.6M | -10.2% |
| Cost of Revenue | $501.5M | -8.8% |
| R&D Expense | $1.7M | +21.4% |
| SG&A Expense | $68.5M | -13.9% |
| Operating Income | -$30.3M | -95.5% |
| Pre-tax Income | -$76.3M | -45.6% |
| Income Tax | $800K | +33.3% |
| Net Income | -$77.1M | -45.5% |
| EPS (Basic) | -$4.12 | -26.0% |
| EPS (Diluted) | -$4.12 | -26.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.7M | -93.8% |
| Accounts Receivable | $102.7M | +6.0% |
| Inventory | $30.7M | -1.0% |
| Current Assets | $149.9M | -35.7% |
| Total Assets | $340.3M | -25.4% |
| Current Liabilities | $126.2M | -9.9% |
| Long-term Debt | $258.3M | -9.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.5M | -86.2% |
| Capital Expenditures | $49.1M | -24.6% |
| Investing Cash Flow | -$32.9M | +35.6% |
| Financing Cash Flow | -$60.5M | -152.1% |
| Free Cash Flow | -$41.6M | -281.7% |
| -$74.2M |
| -606.7% |